AbbVie, the U.S. biopharmaceutical group, has completed the acquisition of Allergan, an Irish-domiciled pharmaceutical company, following receipt of regulatory approval from all government authorities required by the transaction agreement.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.